Assessment of Clinical and Safety Outcomes of Bivalirudin versus Heparin in Patients Undergoing Percutaneous Coronary Intervention

Publication Date

5-14-2022

Presented At:

Florida Residency Conference and American College of Cardiology Conference

Content Type

Presentation

This document is currently not available here.

Share

COinS